Articles by tag: cancer-immunotherapy

Peptideins from 'junk' DNA: 1700 new microproteins kill cancer

Scientists have discovered over 1700 microproteins in non-coding DNA, becoming new targets for cancer. Learn how peptideins change immunotherapy and oncovaccines. Read breakthrough details!

New microproteins in junk DNA: 1700+ peptideins reveal targets for immunotherapy

TransCODE scientists discovered over 1700 microproteins in non-coding DNA. Silencing the OLMALINC gene reduces cancer cell survival by 85%. Learn how peptideins are changing oncology and immunotherapy.

Moderna vaccine shrank tumors in 83% of melanoma patients

mRNA drug mRNA-4359 with Keytruda showed 83% response and 17% complete remissions. Even PD-L1-negative tumors shrank. Learn how a ready-made vaccine teaches the immune system to attack cancer without personalization.